MyMAAT

Introduction

Prior to 2017, the 8-item Modified Morisky Medication Adherence Scale (MMMAS-8) was widely used in Malaysia to assess patient adherence to a drug regimen.

However, starting in 2015, Professor Donald Morisky and her team started charging researchers or practitioners USD 1-1.50 per test for copyright.

• Consequently, the usage of MMMMAS-8 was discontinued and patient adherence was evaluated subjectively.

In August 2023, Wiley Online Library retracted the article since an independent statistical review of the article concluded that the results were misleading due to issues regarding the sensitivity and specificity of the medical adherence scale used.

Malaysia Medication Adherence Assessment Tool (MyMAAT)

The Malaysia Medication Adherence Assessment Tool (MyMAAT) was developed by a multidisciplinary team with expertise in medication adherence and health literacy for use with diabetic patients.

• In March 2020, MyMAAT was introduced at all Ministry of Health facilities to assess patient medication adherence.

External Links

• Pay up or retract? Survey creator's demands for money rile some health researchers, 2017
  
• How should medical researchers respond to false copyright infringement claims?, 2019
  
• Development and validation of Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients, 2020
• Paper that helped form basis of pricy research tool retracted, 2023